On Friday, the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion for Novo Nordisk A/S’ (NYSE:NVO) higher dose of Wegovy (semaglutide 7.2 mg). Novo Nordisk has also applied to the EMA for…
The U.S. Food and Drug Administration (FDA) is reportedly considering adding a boxed warning — the agency's highest-level safety alert — to Covid-19 vaccines, a move that has drawn immediate criticism from outside experts who say there is no evidence…
Eli Lilly and Co. (NYSE:LLY) on Friday shared updated results from the Phase 3 EMBER-3 study of Inluriyo (imlunestrant) for previously treated breast cancer patients. The trial included patients with estrogen receptor positive (ER+), human epidermal growth factor receptor 2–negative…
Arcus Biosciences, Inc. (NYSE:RCUS) on Friday announced the discontinuation of the Phase 3 STAR-221 study, being conducted in partnership with Gilead Sciences, Inc. (NASDAQ:GILD), due to futility. • Arcus Biosciences stock is among today’s weakest performers. Why is RCUS stock…
Tesla, Inc. (NASDAQ:TSLA) remains the undisputed “Robotaxi King” with its Cybercab, but two contenders battle for the rest of the autonomous market. In the race for second place, Rivian Automotive, Inc. (NASDAQ:RIVN) and Lucid Group, Inc. (NASDAQ:LCID) are selling two…
Relay Therapeutics, Inc. (NASDAQ:RLAY) on Friday shared a subset analysis of interim clinical data for zovegalisib (RLY-2608). Subset analyses showed broad activity in patients with PI3Kα-mutated, HR+/HER2- metastatic breast cancer, regardless of prior fulvestrant or other SERD exposure or ESR1…
VivoPower International PLC (NASDAQ:VVPR) shares traded higher on Friday after the company unveiled a major digital-asset joint venture tied to Ripple Labs. The announcement highlighted a new investment structure designed to access private Ripple equity without deploying VivoPower’s own capital.…
RH (NYSE:RH) shares rose Friday even after the luxury retailer missed Q3 earnings estimates and cut full-year guidance. Investors appeared to focus on long-term expansion plans rather than immediate headwinds. Q3 Miss & Guidance Cuts RH reported earnings of $1.71…
An unusual three-way division within the Federal Reserve system has brought several corners of the ETF universe into focus as market participants reassess which corners might be more impacted by changes in respective GDP and interest rate forecasts. As forecast…
Lululemon Athletica Inc (NASDAQ:LULU) shares rallied on Friday, after the company on Thursday reported upbeat third-quarter earnings. • Lululemon Athletica shares are climbing with conviction. What’s behind LULU gains? Here are some key analyst takeaways: BofA Securities analyst Lorraine Hutchinson…